247 related articles for article (PubMed ID: 21226903)
21. Epigenetic silencing of NDRG2 promotes colorectal cancer proliferation and invasion.
Hong SN; Kim SJ; Kim ER; Chang DK; Kim YH
J Gastroenterol Hepatol; 2016 Jan; 31(1):164-71. PubMed ID: 26250123
[TBL] [Abstract][Full Text] [Related]
22. Expression of NDRG2 in esophageal squamous cell carcinoma.
Shi H; Li N; Li S; Chen C; Wang W; Xu C; Zhang J; Jin H; Zhang H; Zhao H; Song W; Feng Q; Feng X; Shen X; Yao L; Zhao Q
Cancer Sci; 2010 May; 101(5):1292-9. PubMed ID: 20331630
[TBL] [Abstract][Full Text] [Related]
23. Prediction of colorectal cancer relapse and prognosis by tissue mRNA levels of NDRG2.
Chu D; Zhang Z; Li Y; Wu L; Zhang J; Wang W; Zhang J
Mol Cancer Ther; 2011 Jan; 10(1):47-56. PubMed ID: 21220491
[TBL] [Abstract][Full Text] [Related]
24. Tissue array for Tp53, C-myc, CCND1 gene over-expression in different tumors.
Liu GY; Luo Q; Xiong B; Pan C; Yin P; Liao HF; Zhuang WC; Gao HZ
World J Gastroenterol; 2008 Dec; 14(47):7199-207. PubMed ID: 19084934
[TBL] [Abstract][Full Text] [Related]
25. NDRG2 acts as a negative regulator downstream of androgen receptor and inhibits the growth of androgen-dependent and castration-resistant prostate cancer.
Yu C; Wu G; Li R; Gao L; Yang F; Zhao Y; Zhang J; Zhang R; Zhang J; Yao L; Yuan J; Li X
Cancer Biol Ther; 2015; 16(2):287-96. PubMed ID: 25756511
[TBL] [Abstract][Full Text] [Related]
26. Tumor suppressor candidate gene, NDRG2 is frequently inactivated in human glioblastoma multiforme.
Zhou B; Tang Z; Deng Y; Hou S; Liu N; Lin W; Liu X; Yao L
Mol Med Rep; 2014 Aug; 10(2):891-6. PubMed ID: 24840052
[TBL] [Abstract][Full Text] [Related]
27. Expression of human NDRG2 by myeloid dendritic cells inhibits down-regulation of activated leukocyte cell adhesion molecule (ALCAM) and contributes to maintenance of T cell stimulatory activity.
Choi SC; Kim KD; Kim JT; Kim JW; Lee HG; Kim JM; Jang YS; Yoon DY; Kim KI; Yang Y; Cho DH; Lim JS
J Leukoc Biol; 2008 Jan; 83(1):89-98. PubMed ID: 17911180
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of NDRG2 gene expression in human colorectal cancer involves promoter methylation and microRNA-650.
Feng L; Xie Y; Zhang H; Wu Y
Biochem Biophys Res Commun; 2011 Mar; 406(4):534-8. PubMed ID: 21352815
[TBL] [Abstract][Full Text] [Related]
29. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
[TBL] [Abstract][Full Text] [Related]
30. Expression of NDRG2 in human lung cancer and its correlation with prognosis.
Li SJ; Wang WY; Li B; Chen B; Zhang B; Wang X; Chen CS; Zhao QC; Shi H; Yao L
Med Oncol; 2013 Mar; 30(1):421. PubMed ID: 23307246
[TBL] [Abstract][Full Text] [Related]
31. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
[TBL] [Abstract][Full Text] [Related]
32. [Expression and significance of new candidate tumor suppressor gene N-Myc downstream-regulated gene 2 in colorectal cancer].
Shi H; Wang WZ; Yao LB; Zhang J; Yin Q; Xu CS; Chu DK; Dong GL; Zhang HW; Li JP
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):281-4. PubMed ID: 19434539
[TBL] [Abstract][Full Text] [Related]
33. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
Li B; Shao Q; Ji D; Li F; Guo X; Chen G
Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
[TBL] [Abstract][Full Text] [Related]
34. Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma.
Tepel M; Roerig P; Wolter M; Gutmann DH; Perry A; Reifenberger G; Riemenschneider MJ
Int J Cancer; 2008 Nov; 123(9):2080-6. PubMed ID: 18709645
[TBL] [Abstract][Full Text] [Related]
35. NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second promoter in human gastrointestinal cancers.
Yamamura A; Miura K; Karasawa H; Motoi F; Mizuguchi Y; Saiki Y; Fukushige S; Sunamura M; Shibata C; Unno M; Horii A
Biochem Biophys Res Commun; 2017 Feb; 484(1):138-143. PubMed ID: 28093228
[TBL] [Abstract][Full Text] [Related]
36. Expression of BMI-1 and Mel-18 in breast tissue--a diagnostic marker in patients with breast cancer.
Riis ML; Lüders T; Nesbakken AJ; Vollan HS; Kristensen V; Bukholm IR
BMC Cancer; 2010 Dec; 10():686. PubMed ID: 21162745
[TBL] [Abstract][Full Text] [Related]
37. Tumor grade-related NDRG2 gene expression in primary and recurrent intracranial meningiomas.
Skiriute D; Tamasauskas S; Asmoniene V; Saferis V; Skauminas K; Deltuva V; Tamasauskas A
J Neurooncol; 2011 Mar; 102(1):89-94. PubMed ID: 20607352
[TBL] [Abstract][Full Text] [Related]
38. NDRG2 expression and mutation in human liver and pancreatic cancers.
Hu XL; Liu XP; Lin SX; Deng YC; Liu N; Li X; Yao LB
World J Gastroenterol; 2004 Dec; 10(23):3518-21. PubMed ID: 15526377
[TBL] [Abstract][Full Text] [Related]
39. AKT-1, -2, and -3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon.
Zinda MJ; Johnson MA; Paul JD; Horn C; Konicek BW; Lu ZH; Sandusky G; Thomas JE; Neubauer BL; Lai MT; Graff JR
Clin Cancer Res; 2001 Aug; 7(8):2475-9. PubMed ID: 11489829
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of N-myc downstream-regulated gene 2 in prostatic carcinoma.
Yu C; Wu G; Dang N; Zhang W; Zhang R; Yan W; Zhao Y; Gao L; Wang Y; Beckwith N; Yuan J; Yao L
Cancer Biol Ther; 2011 Aug; 12(4):304-13. PubMed ID: 21623166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
